Introduction. Severe acne vulgaris is a chronic inflammatory dermatological disease associated with persistent lesions, a high risk of scarring, and significant psychosocial burden. Its management is often limited by the adverse effects and poor tolerability of systemic therapies. Although oral isotretinoin remains the standard treatment for severe acne, growing concerns regarding systemic side effects have increased interest in non-pharmacological treatment modalities, including long-pulsed Nd:YAG laser therapy.
Aim. The aim of this study was to compare the clinical efficacy of long-pulsed Nd:YAG laser therapy with oral isotretinoin in adult patients with severe acne vulgaris.
Materials and Methods. A randomized clinical trial was conducted in adult patients diagnosed with severe acne vulgaris. Participants were randomly allocated into two treatment groups. One group received standard systemic therapy with oral isotretinoin, while the second group underwent a structured course of long-pulsed Nd:YAG laser therapy. Clinical response was assessed using a validated acne severity grading scale at baseline and during scheduled follow-up visits. Treatment outcomes were evaluated based on changes in acne severity and overall clinical improvement.
Results. Both treatment modalities resulted in significant clinical improvement over the course of therapy. However, patients treated with long-pulsed Nd:YAG laser therapy demonstrated a more pronounced reduction in acne severity compared with those receiving oral isotretinoin. Clinical improvement in the laser-treated group was observed earlier and was characterized by a marked reduction in inflammatory lesions and overall disease activity.
Conclusion. Long-pulsed Nd:YAG laser therapy demonstrated superior clinical efficacy compared with oral isotretinoin in the treatment of severe acne vulgaris. These findings support the role of Nd:YAG laser therapy as an effective and promising non-pharmacological alternative, particularly for patients in whom systemic therapy is contraindicated or poorly tolerated.
References
1. Li, Y., Zhu, J., Zhang, Y. et al. Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects. Lasers Med Sci 36, 657–665 (2021). https://doi.org/10.1007/s10103-020-03113-z
2. Chen S, Wang Y, Ren J et al (2019) Efficacy and safety of intense pulsed light in the treatment of inflammatory acne vulgaris with a novel filter. J Cosmet Laser Ther 21(6):323–327
3. Barakat MT, Moftah NH, El Khayyat MA et al (2016) Significant reduction of inflammation and sebaceous glands size in acne vulgaris lesions after intense pulsed light treatment. Dermatol Ther 30(1):e12418
4. Yap FB (2017) Safety and efficacy of fixed-dose 10 mg daily isotretinoin treatment for acne vulgaris in Malaysia. J Cosmet Dermatol 16(3):348–352. https://doi.org/10.1111/jocd.12268
5. Barakat MT, Moftah NH, El Khayyat MA, Abdelhakim ZA (2017) Significant reduction of inflammation and sebaceous glands size in acne vulgaris lesions after intense pulsed light treatment. Dermatol Ther 30(1). https://doi.org/10.1111/dth.12418
6. Xu Y, Wang H, Guo L, Hamblin MR, Wen X. Combinations of energy-based devices plus isotretinoin for management of acne and acne scars: a systematic review. J Cosmet Dermatol. 2024. https://doi.org/10.1111/jocd.16407
7. Xue, H., Ye, D., Huang, SL. et al. Early acne scar intervention with 1064 nm picosecond laser in patients receiving oral isotretinoin: a randomized split-face controlled pilot study. Lasers Med Sci 38, 40 (2023). https://doi.org/10.1007/s10103-022-03702-0
|